Discussions relating to homeopathy have polarized ardent supporters and cynical skeptics. Supporters point to the occasional studies, which clearly indicate clinical efficacy of certain homeopathic solutions when directly compared to control solutions. Supporters are far less convincing when they ascribe efficacy to the “Law of Similars.” This law states that the relief of a particular symptom in a patient can best be accomplished by using highly diluted compounds that when individually administered in large quantity to healthy individuals, will induce the exact same symptom as that affecting the patient. Dr. Samuel Hahnemann (1755-1843), the father of homeopathy, extended the concept of hormesis in proposing this mode of action. Hormesis refers to a hypothetical rebounding response to an applied stimulus, which overshoots the original measure of activity. For example, it has been suggested that oxidative therapy may trigger an anti-oxidant response well beyond that required to neutralize the administered oxidative stress; leading to a net beneficial gain in anti-oxidant activity.
The “Laws of Similars” has never been tested in direct crossover comparisons between supposedly symptom specific homeopathic remedies. Rather, the postulated law may have been a self-serving argument by homeopathic practitioners for the continuing need of their diagnostic acumen and also for their specialized expertise in formulating personalized remedies.
The unsubstantiated “Law of Similars” is, in fact, contrary to actual experience of wide-ranging clinical benefits of certain homeopathic formulations. One example is the product originally called HANSI, for “homeopathic activator of the system immune.” Based on research by the author, the product was modified and renamed Enercel by its US manufacturer. Enercel is effective in alleviating childhood diarrhea, asthma, tuberculosis and HIV. It also promotes wound healing without scaring.
Broadly based medical benefits have been similarly described to various therapeutic modalities beyond homeopathy. One example is the largely forgotten 1930’s reports of disease regression from intravenously injected diluted hydrochloric acid. The effects were unrelated to induced changes in pH, since acidic patients tended towards normal pH levels, as did patients with an initially elevated pH. Other solutions for which there have been broadly based medical claims are chlorine dioxide, (commonly referred to as Halox or NMS), humic/fulvic acid, zeolite, mica, colloidal silver and shungite. Each type of solution is promoted as having medical benefits comparable to those ascribed to effective homeopathic formulations.
All of these observations are consistent with the proposed alternative cellular energy (ACE) pathway. This pathway is distinct from the energy that cells derived from food metabolism. It is reflected in a dynamic quality of the body’s fluids, seemingly associated with a reduction in hydrogen bonding between fluid molecules. This dynamic property can be easily induced in water using the above-mentioned substances. The active substances are postulated to capture an environmental energy termed KELEA (kinetic energy limiting electrostatic attraction).
The body can also produce KELEA attracting materials in the form of particles and self-assembling threads. They can readily be detected in certain localized skin lesions, e.g. herpes simplex virus (HSV) ulcers and can also be more widely disseminated in other parts of the body, including uninvolved skin, saliva and urine. These materials have been termed ACE pigments and have been likened to small batteries with energy transducing (converting) properties. When partially charged, they will fluoresce under ultraviolet (UV) light illumination. Uncharged ACE pigments do not directly fluoresce with UV light, but will do so with the addition of certain dyes, including neutral red dye. Fully charged ACE pigments will not fluoresce in either the absence or presence of neutral red dye. It is possible; therefore, the monitor a person’s ACE pathway by testing areas of skin, saliva and urine for UV fluorescence, with and without added neutral red dye.
Among the simple methods for enhancing the ACE pathway are the consumption of KELEA activated fluids and the placement of KELEA attracting compounds in close vicinity to the skin. Protocols for both approaches have been developed.
The stage is now set for Institutional Review Board (IRB) approved clinical studies using KELEA activated water and KELEA attracting compounds. These studies can quickly determine the optimal means of enhancing the body’s ACE pathway. These protocols are indicated in a wide range of both infectious and non-infectious illnesses. Included in the former are neuropsychiatric disorders due to stealth adapted viruses. Since these derivative viruses do not elicit an inflammatory response, the diseases they cause have largely gone unrecognized as being infectious in origin. Other common virus infections for immediate targeting are those caused by conventional herpes viruses, hepatitis viruses, HIV and even Ebola virus.
Many common non-infectious diseases can also be ascribed to an insufficiency of cellular energy obtainable via normal metabolism. The energy insufficiency can occur from impaired availability of i) oxygen, as with chronic obstructive pulmonary disease (COPD), ii) blood supply, as in cardiovascular and cerebrovascular diseases and; iii) nutrients, as in common metabolic disorders, including diabetes. Clinical improvements in all of these illnesses are to be expected by the increased availability of energy via the ACE pathway.